Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth (Q28205889)

1

0 references

Tomoyuki Saito

2

0 references

Tohru Tsukui

3

0 references

Masayo Fujita

4

0 references

Masami Muramatsu

6

0 references

Yasuyoshi Ouchi

7

0 references

Satoshi Inoue

Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein

8

0 references

language of work or name

English

0 references

publication date

20 June 2002

0 references

published in

Nature

0 references

volume

417

0 references

page(s)

871-5

0 references

issue

6891

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Estrogen receptors: how do they control reproductive and nonreproductive functions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

21 January 2018

RING for destruction?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Efp as a primary estrogen-responsive gene in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

PML protein isoforms and the RBCC/TRIM motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

RING finger proteins: mediators of ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Mechanisms underlying ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

inferred from DOI database lookup

7 January 2021

based on heuristic

One ring to rule a superfamily of E3 ubiquitin ligases

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826

inferred from DOI database lookup

7 January 2021

based on heuristic

p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1

1 reference

https://api.crossref.org/works/10.1038%2FNATURE00826